The Softer Side of Sports Medicine
This article was originally published in Start Up
Executive SummaryResorbable biomaterials and improved arthroscopic tools form the backbone of innovation in sports medicine, and should, along with the aging baby-boomer population, spur growth in the field
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.